Skip to content

AnaptysBio, Inc. ANAB Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Operating margin20.4%+146pp-125.9%+832pp-958.3%+161pp-1,119.4%-1,029pp
EBITDA margin20.7%+146pp-125.3%+829pp-954.5%+158pp-1,112.9%-1,024pp
Free cash flow margin8.4%+157pp-148.7%+560pp-708.8%+10.1pp-718.9%
Efficiency
Asset turnover0.6×+0.4×0.2×+0.2×0.0×-0.1×
Liquidity
Current ratio9.1×-0.4×9.5×-1.4×10.9×-6.3×17.2×-17.2×
Quick ratio9.1×-0.4×9.5×-1.4×10.9×-6.3×17.2×-17.2×
Cash ratio6.2×+3.5×2.7×+1.7×-1.8×2.7×-28.1×
Leverage
Debt-to-equity-0.2×0.2×0.0×0.2×+0.1×0.1×0.0×
Debt-to-assets0.0×0.0×0.0×0.0×
Net debt / EBITDA-4.9×
Per Share
Book value per share$1.29-48.2%$2.50-23.7%$3.27-64.8%$9.31-28.4%
Valuation
Market capitalization$1.34B+233%$402.88M-29.2%$569.24M-35.4%$881.1M-8.3%
Enterprise value$1.1B+273%$295.83M-46.3%$551.09M-33.5%$829.24M+70.7%
Price / sales5.7×+1.3×4.4×-28.8×33.2×-52.5×85.7×+70.4×
Price / book36.1×+30.4×5.7×-0.8×6.5×+3.1×3.4×+0.7×
EV / EBITDA22.8×
EV / sales4.7×+1.5×3.2×-28.9×32.1×-48.5×80.6×+72.9×
Free cash flow yield1.5%+35.1pp-33.7%-12.3pp-21.4%-13.0pp-8.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do AnaptysBio, Inc.'s ratios come from?
Every ratio is computed from AnaptysBio, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.